Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 1
2018 1
2020 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Eosinophilia secondary to lenalidomide therapy.
Escudero-Vilaplana V, Osorio-Prendes S, Collado-Borrell R, González-Arias E, Sanjurjo-Sáez M. Escudero-Vilaplana V, et al. Among authors: osorio prendes s. J Clin Pharm Ther. 2018 Apr;43(2):273-275. doi: 10.1111/jcpt.12611. Epub 2017 Aug 17. J Clin Pharm Ther. 2018. PMID: 28833364
COVID-19 coagulopathy: An in-depth analysis of the coagulation system.
Martín-Rojas RM, Pérez-Rus G, Delgado-Pinos VE, Domingo-González A, Regalado-Artamendi I, Alba-Urdiales N, Demelo-Rodríguez P, Monsalvo S, Rodríguez-Macías G, Ballesteros M, Osorio-Prendes S, Díez-Martín JL, Pascual Izquierdo C. Martín-Rojas RM, et al. Among authors: osorio prendes s. Eur J Haematol. 2020 Dec;105(6):741-750. doi: 10.1111/ejh.13501. Epub 2020 Aug 19. Eur J Haematol. 2020. PMID: 32749010 Free PMC article.
[Suspected itchy rash secondary to lenalidomide].
Escudero-Vilaplana V, Osorio Prendes S, Sanjurjo Sáez M. Escudero-Vilaplana V, et al. Among authors: osorio prendes s. Farm Hosp. 2014 Nov 3;38(6):495-6. doi: 10.7399/fh.2014.38.6.8176. Farm Hosp. 2014. PMID: 25542665 Free article. Spanish. No abstract available.
Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study.
Vicente-Valor J, Rodríguez-González C, Ferris-Villanueva M, Chamorro-de-Vega E, Romero-Jiménez R, Gómez-Costas D, Herrero-Bermejo S, Tejerina-Picado F, Osorio-Prendes S, Oarbeascoa-Royuela G, Herranz-Alonso A, Sanjurjo-Sáez M. Vicente-Valor J, et al. Among authors: osorio prendes s. Pharmacol Rep. 2023 Oct;75(5):1254-1264. doi: 10.1007/s43440-023-00519-8. Epub 2023 Sep 1. Pharmacol Rep. 2023. PMID: 37656351
Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing.
Andrés-Zayas C, Suárez-González J, Chicano-Lavilla M, Bastos Oreiro M, Rodríguez-Macías G, Font López P, Osorio Prendes S, Oarbeascoa Royuela G, García Ramírez P, Nieves Salgado R, Gómez-Centurión I, Carbonell Muñoz D, Muñiz P, Kwon M, Díez-Martín JL, Buño I, Martínez-Laperche C. Andrés-Zayas C, et al. Among authors: osorio prendes s. Cancers (Basel). 2023 Feb 2;15(3):944. doi: 10.3390/cancers15030944. Cancers (Basel). 2023. PMID: 36765901 Free PMC article.